Literature DB >> 26417433

Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection.

Katrina M Pollock1, Damien J Montamat-Sicotte1, Graham S Cooke2, Moses S Kapembwa3, Onn M Kon4, Lisa Grass1, Robert D Sampson5, Graham P Taylor2, Ajit Lalvani1.   

Abstract

HIV-infected individuals with severe immunodeficiency are at risk of opportunistic infection (OI). Tuberculosis (TB) may occur without substantial immune suppression suggesting an early and sustained adverse impact of HIV on Mycobacterium tuberculosis (MTB)-specific cell mediated immunity (CMI). This prospective observational cohort study aimed to observe differences in OI-specific and MTB-specific CMI that might underlie this. Using polychromatic flow cytometry, we compared CD4+ responses to MTB, cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Candida albicans in individuals with and without HIV infection. MTB-specific CD4+ T-cells were more polyfunctional than virus specific (CMV/EBV) CD4+ T-cells which predominantly secreted IFN-gamma (IFN-γ) only. There was a reduced frequency of IFN-γ and IL-2 (IL-2)-dual-MTB-specific cells in HIV-infected individuals, which was not apparent for the other pathogens. MTB-specific cells were less differentiated especially compared with CMV-specific cells. CD127 expression was relatively less frequent on MTB-specific cells in HIV co-infection. MTB-specific CD4+ T-cells PD-1 expression was infrequent in contrast to EBV-specific CD4+ T-cells. The variation in the inherent quality of these CD4+ T-cell responses and impact of HIV co-infection may contribute to the timing of co-infectious diseases in HIV infection.

Entities:  

Keywords:  Candida albicans; Epstein-Barr virus; HIV; Mycobacterium tuberculosis; cytomegalovirus

Year:  2015        PMID: 26417433      PMCID: PMC4578516          DOI: 10.1002/iid3.50

Source DB:  PubMed          Journal:  Immun Inflamm Dis        ISSN: 2050-4527


  36 in total

1.  Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy.

Authors:  M Nkuize; S De Wit; V Muls; M Arvanitakis; M Buset
Journal:  HIV Med       Date:  2010-02-08       Impact factor: 3.180

Review 2.  Cytokine control of memory T-cell development and survival.

Authors:  Kimberly S Schluns; Leo Lefrançois
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

3.  Detection of polyfunctional Mycobacterium tuberculosis-specific T cells and association with viral load in HIV-1-infected persons.

Authors:  Cheryl L Day; Nompumelelo Mkhwanazi; Sharon Reddy; Zenele Mncube; Mary van der Stok; Paul Klenerman; Bruce D Walker
Journal:  J Infect Dis       Date:  2008-04-01       Impact factor: 5.226

4.  CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection.

Authors:  Richard M Dunham; Barbara Cervasi; Jason M Brenchley; Helmut Albrecht; Amy Weintrob; Beth Sumpter; Jessica Engram; Shari Gordon; Nichole R Klatt; Ian Frank; Donald L Sodora; Daniel C Douek; Mirko Paiardini; Guido Silvestri
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

5.  Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy.

Authors:  Alexandre Harari; Stéphanie Petitpierre; Florence Vallelian; Giuseppe Pantaleo
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113

6.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

7.  High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening.

Authors:  Tolu Oni; Rachael Burke; Relebohile Tsekela; Nonzwakazi Bangani; Ronnett Seldon; Hannah P Gideon; Kathryn Wood; Katalin A Wilkinson; Tom H M Ottenhoff; Robert J Wilkinson
Journal:  Thorax       Date:  2011-05-31       Impact factor: 9.139

Review 8.  Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection.

Authors:  Maria R Petrara; Riccardo Freguja; Ketty Gianesin; Marisa Zanchetta; Anita De Rossi
Journal:  Front Microbiol       Date:  2013-10-18       Impact factor: 5.640

9.  HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria.

Authors:  Barbara Kalsdorf; Thomas J Scriba; Kathryn Wood; Cheryl L Day; Keertan Dheda; Rodney Dawson; Willem A Hanekom; Christoph Lange; Robert J Wilkinson
Journal:  Am J Respir Crit Care Med       Date:  2009-09-24       Impact factor: 21.405

10.  Characterization of the CD4+ T cell response to Epstein-Barr virus during primary and persistent infection.

Authors:  Elisabeth Amyes; Chris Hatton; Damien Montamat-Sicotte; Nancy Gudgeon; Alan B Rickinson; Andrew J McMichael; Margaret F C Callan
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  4 in total

1.  PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection.

Authors:  Katrina M Pollock; Damien J Montamat-Sicotte; Lisa Grass; Graham S Cooke; Moses S Kapembwa; Onn M Kon; Robert D Sampson; Graham P Taylor; Ajit Lalvani
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

2.  Selective reduction of IFN-γ single positive mycobacteria-specific CD4+ T cells in HIV-1 infected individuals with latent tuberculosis infection.

Authors:  Catherine Riou; Rubina Bunjun; Tracey L Müller; Agano Kiravu; Zekarias Ginbot; Tolu Oni; Rene Goliath; Robert J Wilkinson; Wendy A Burgers
Journal:  Tuberculosis (Edinb)       Date:  2016-08-09       Impact factor: 3.131

Review 3.  Local and Long-Distance Calling: Conversations between the Gut Microbiota and Intra- and Extra-Gastrointestinal Tract Infections.

Authors:  Joshua E Denny; Whitney L Powell; Nathan W Schmidt
Journal:  Front Cell Infect Microbiol       Date:  2016-04-11       Impact factor: 5.293

4.  Loss of T-Cell Multifunctionality and TCR-Vβ Repertoire Against Epstein-Barr Virus Is Associated With Worse Prognosis and Clinical Parameters in HIV+ Patients.

Authors:  Diana M Hernández; Sandra Valderrama; Sandra Gualtero; Catalina Hernández; Marcos López; Maria Victoria Herrera; Julio Solano; Susana Fiorentino; Sandra Quijano
Journal:  Front Immunol       Date:  2018-10-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.